Table D

Factors influencing 3 month outcomes. Each stage of the modeling process is shown. The variable removed at each step is indicated by an asterisk (*).

β95% CI ( β )P-valueR2
Initial model (maximum correlation coefficient −0.412)
n=305Age0.01(0.00 – 0.02)0.0470.486
Partnered−0.04(−0.30 – 0.22)0.747
Smoker−0.17(−0.44 – 0.10)0.222
Diabetes0.22(−0.04 – 0.48)0.101
Prior stroke*−0.03(−0.31 – 0.26)0.862
Severe PVWMD0.49(0.07 – 0.91)0.021
Pre-stroke Rankin0.22(0.13 – 0.31)<0.001
Post-stroke Rankin0.54(0.42 – 0.66)<0.001
Estimated NIHSS0.04(0.01 – 0.06)0.010
Thrombolytics−0.34(−0.86 – 0.19)0.214

Step 2
n=305Age0.01(0.00 – 0.02)0.0440.486
Partnered*−0.04(−0.30 – 0.22)0.752
Smoker−0.17(−0.44 – 0.10)0.215
Diabetes0.22(−0.04 – 0.48)0.103
Severe PVWMD0.49(0.07 – 0.91)0.021
Pre-stroke Rankin0.22(0.13 – 0.30)<0.001
Post-stroke Rankin0.53(0.41 – 0.65)<0.001
Estimated NIHSS0.04(0.01 – 0.06)0.010
Thrombolytics−0.33(−0.86 – 0.19)0.216

Step 3
n=331Age0.01(0.00 – 0.02)0.0420.492
Smoker*−0.18(−0.43 – 0.07)0.160
Diabetes0.25(0.01 – 0.49)0.043
Severe PVWMD0.47(0.07 – 0.87)0.022
Pre-stroke Rankin0.19(0.11 – 0.28)<0.001
Post-stroke Rankin0.54(0.43 – 0.65)<0.001
Estimated NIHSS0.04(0.01 – 0.06)0.006
Thrombolytics−0.37(−0.86 – 0.13)0.144

Step 4
n=331Age0.01(0.00 – 0.02)0.0150.489
Diabetes0.27(0.02 – 0.51)0.032
Severe PVWMD0.46(0.06 – 0.86)0.025
Pre-stroke Rankin0.20(0.11 – 0.28)<0.001
Post-stroke Rankin0.55(0.43 – 0.66)<0.001
Estimated NIHSS0.04(0.01 – 0.06)0.004
Thrombolytics*−0.40(−0.89 – 0.10)0.115

Final model
n=332Age0.01(0.00 – 0.02)0.0080.484
Diabetes0.27(0.02 – 0.51)0.031
Severe PVWMD0.47(0.07 – 0.87)0.021
Pre-stroke Rankin0.20(0.12 – 0.28)<0.001
Post-stroke Rankin0.56(0.46 – 0.67)<0.001
Estimated NIHSS0.03(0.00 – 0.05)0.016

Note: repeating these analyses without imaging data (excluding pvwmd) results in the same final model and an R2 of 0.485 – one might assume knowing pvwmd status on all cases would have improved this R2

-